The World Health Organization (WHO) has added a new set of drugs for obesity and diabetes to its essential medicines list, alongside treatments for cancer and cystic fibrosis. Cheap generic versions ...

Recent research reveals that metformin, a long-used diabetes drug, may function through the brain more than previously ...

Researchers developed a model using routine clinical data to identify optimal glucose-lowering therapies for patients with type 2 diabetes (T2D). Individuals receiving model-predicted optimal therapy ...

Andrew Stewart, MD, director, Mount Sinai Diabetes, Obesity, and Metabolism Institute, New York Now, we know that part of the problem also lies with your beta cells. These are the cells in your ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), significantly improving access to diabetes treatment. The glucagon-like peptide-1 ...

Medicare Part D spending on diabetes drugs increased 364% from 2019 to 2023, driven by GLP-1 and SGLT-2 inhibitors. Metformin spending decreased by 5%, contrasting with the surge in other diabetes ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is ...

Physicians have hesitated to prescribe GLP-1RA medications, such as those with brand names of Ozempic and Victoza, to patients with a history of pancreatitis because it was believed they could ...

A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type ...

While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal ...